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In a previous study, Vanabin2, a member of a family of V(IV)-binding proteins, or Vanabins, was shown to  act as a V(V)-reductase. The 
current study assesses the ability of Vanabin2 to reduce various transition metal ions in vitro. An NADPH-coupled oxidation assay 
yielded no evidence of reduction activity with the hexavalent transition metal anions, MoVIO42- and WVIO42-, or with three divalent 
cations, Mn(II), Ni(II), and Co(II). Although Cu(II) is readily reduced by glutathione and is gradually oxidized in air, this process was 
not affected by the presence of Vanabin2. In the experiments conducted thus far, Vanabin2 acts only as a V(V)-reductase. This high 10 
selectivity may account for the metal ion selectivity of vanadium accumulation in ascidians. 
 
1. Introduction 
The unusual ability of ascidians (sea squirts) to accumulate high 
levels of vanadium ions has been attracting attention in biological 15 
and chemical disciplines for a century. The maximum 
concentration of vanadium can reach 350 mM in vanadocytes of 
Ascidia gemmata, belonging to the class Ascidiidae, and is 
thought to be the highest metal accumulation factor of any living 
organism 1. Vanadium usually exists as VV in HVO42- or H2VO4- 20 
in natural aquatic environments. These ions are reduced to VIII 
via a VIV state (VO2+) during assimilation 2,1. Usually, vanadium 
ions are stored in the vacuoles of signet ring cells, which are a 
type of blood cell often referred to as vanadocytes (vanadium-
accumulating cells) 3. One of the biggest unknowns is how and 25 
why ascidians accumulate only vanadium at these extremely high 
levels. Of particular interest is how ascidians select vanadium out 
of the many transition metal ions. 
 Ongoing research during the last two decades has identified 
many proteins involved in the process of accumulating and 30 
reducing vanadium in vanadocytes, blood plasma, and the 
digestive tract of ascidians. These proteins include vacuolar-type 
H+-ATPase 4, a chloride channel 5, a sulfate transporter 6, 
enzymes of the pentose-phosphate pathway 7-10, a vanadium 
transporter Nramp 11, and VIV-binding proteins Vanabins 12-15. 35 
 Among these, the proteins that could be responsible for the 
selective transport of vanadium are the Vanabins and Nramp. 
Vanabins commonly possess 18 conserved cysteine residues and 
constitute a unique protein family present only in vanadium-rich 
ascidians. The most studied Vanabin is Vanabin2, which has been 40 
isolated from Ascidia sydneiensis samea 15. The three-
dimensional structure of Vanbin2 was determined by NMR, 
which revealed 18 cysteines that form nine disulfide (SS) bonds 
between specific amino acid residues 16. Nramp is expressed on 
the vacuolar membrane of vanadocytes and acts as a VO2+/H+-45 
antiporter 11. Vanadium transport by Nramp is inhibited by excess 
amounts of FeII, MnII, CuII, or ZnII. Another possible mechanism 
of metal ion selectivity would be a transporter expressed on the 
cytoplasmic membrane of vanadocytes. Several ideas related to 
such a transporter have been post17 but as of yet there have been 50 
no confirmative results. 
 Although Vanabin2 was originally isolated as a VIV-binding 
protein, it was found to adopt an SS/SH intermediate structure 
and can act as a VV-reductase 18. Vanabin2 can also bind FeIII, 
CuII, CoII, MnII, and ZnII 19,20 although it has not been determined 55 
whether Vanabin2 can reduce any metal ions other than 
vanadium. Therefore, the current report assesses the hypothesis 
that Vanabins determine the specificity of vanadium 
accumulation and reduction in ascidians. Specifically, the ability 
of Vanabin2 to reduce alternate transition metal ions, including 60 
MnII, CoII,  NiII, CuII, MoVIO42-, and WVIO42- was evaluated.  
2. Materials and methods 
2.1. Reagents 
 
Fig. 1. Reduction of metal ions by Vanabin2 coupled with the oxidation of NADPH. 
 
Dithiothreitol (DTT), 2-mercaptoethanol (2-ME), and reduced 
glutathione (GSH) were purchased from Wako Pure Chemical 
Industries. Sodium orthovanadate (Na3VO4; >99.9%) was 
purchased from Sigma-Aldrich Co. Other metal reagents were all 
ultrapure reagents (MnCl2･4H2O, CoSO4･7H2O, NiCl2･6H2O, 5 
CuCl2 ･ 2H2O, Na2MoO4 ･ 2H2O, and Na2WO4 ･ 2H2O; >95%) 
purchased from Wako. NADPH and glutathione reductase (GR) 
were obtained from the Oriental Yeast Company. Bathocuproine 
disulfonic acid disodium salt (BCS) was obtained from Nacalai 
Tesque, Inc. 10 
2.2 Preparation of recombinant protein 
Recombinant Vanabin2 protein was prepared in accordance with 
procedures published previously 18. Briefly, the pMAL-c plasmid 
containing the Vanabin2 coding region 15 was introduced into 
Escherichia coli strain TB1. The transformed cells were 15 
incubated in Luria–Bertani (LB) medium containing 50 μg/mL 
ampicillin and 0.5 mM isopropyl β-D-1-thiogalactopyranoside 
(IPTG). The cells were harvested, resuspended in a lysis buffer 
(10 mM Na2HPO4, 30 mM NaCl, 10 mM EDTA, 10 mM EGTA, 
0.25% Tween 20, 10 mM 2-ME, pH 7.0) containing 4 M urea and 20 
then sonicated using a UH-150 ultrasonic homogenizer (SMT 
Company). The fusion protein was purified from the soluble 
cellular fraction by affinity chromatography using amylose resin 
in accordance with the manufacturer’s protocol (New England 
Biolabs). The protein was cleaved at the MBP junction by 25 
incubation with Factor Xa and the released Vanabin2 was 
purified through an anion-exchange column filled with DEAE-
Sephacel resin (GE Healthcare). The eluted protein was dialyzed 
four times in 100 volumes of 50 mM Tris–HCl (pH 7.4) for use in 
vanadium reductase activity assays. Prior to use, the purity of the 30 
Vanabin2 was confirmed by SDS-PAGE. 
2.3. NADPH-coupled oxidation assays 
Metal reductase activity was measured using an NADPH-coupled 
oxidation assay as described previously 18. The assay buffer 
contained 50 mM Tris-HCl (pH 7.4), 200 μM NADPH, 0.25 35 
U/mL glutathione reductase (GR), and 2 mM GSH. In assays 
using cobalt, the buffer was replaced with citrate/sodium citrate 
buffer (2:3 mixture of 100 mM stock; pH 4.7 adjusted by NaOH) 
as described in the Results and Discussion section. Vanabin2 was 
added to a final concentration of 2 or 4 μM in each tube, except 40 
for the negative control tube, and the solutions were pre-heated at 
18°C for at least 15 min. Metal ion solutions were prepared by 
dissolving ultra pure reagent in ultra pure water at 10 mM. For 
Na3VO4, the solution was heated at 65°C until it became colorless. 
Metal solutions were added to a final concentration of 1 mM. 45 
NADPH oxidation was monitored at 340 nm for 60 min at 18°C 
using a U-2900 spectrophotometer equipped with a 
thermoelectric cell holder (Hitachi Co. Ltd.). 
2.4. Measurement of CuI using BCS 
Concentrations of CuI was determined using bathocuproine 50 
(BCS) 21. Vanabin2 was mixed with NADPH, GR, and GSH in 
Tris buffer in each tube, except for the negative control tube, and 
pre-heated at 18°C for at least 15 min. CuIICl2 solution was added 
to a final concentration of 2 mM and incubated at 18°C. The 
assay buffer contained 50 mM Tris-HCl (pH 7.4), 200 μM 55 
NADPH, 0.25 U/mL glutathione reductase (GR), 2 mM GSH, 2 
μM Vanabin2 and 2 mM CuIICl2 in a 1-mL volume. At specific 
time intervals, aliquots (125 µL) were removed and mixed with 
40−µL BCS (5 mg/ml), 100 µl EDTA (1.2 mg/mL),  400−µL 
McIlvaine’s buffer (a mixture of 0.2 M Na2HPO4 and 0.1 M citric 60 
acid, pH 7.2) and 960-µL water. The solution absorbance due to 
the formation of CuI-BCS was measured at 480 nm within 15 min 
using the U-2900 spectrophotometer. 
 
 
 
 
 
Fig 2. NADPH-coupled assays for the (A) reduction of 
VV, (B) reduction of MoVI, and (C) reduction of WVI. 
Solid line with solid rectangles correspond to the reaction 
with 4 µM Vanabin2. Dashed line with open rectangles 
corresponds to the reaction with 2 µM Vanabin2. Dotted 
line with open triangles shows data acquired without 
Vanabin2. The horizontal axis indicates the time after 
initiation of the reaction. The vertical axis indicates the 
decrease in absorbance at 340 nm due to NADPH 
oxidation. 
 3. Results and discussion 
3.1. Reduction of penta- or hexavalent transition metal anions 
by Vanabin2 coupled with NADPH oxidation 
As reported previously, Vanabin2 was shown to reduce 
pentavalent vanadium (VVO43-) to a tetravalent form (VIVO2+) 5 
when coupled with NADPH, glutathione reductase (GR), and 
glutathione (GSH/GSSG) 18. We assessed whether Vanabin2 can 
reduce other transition metal ions according to the reaction 
cascade shown in Fig. 1.  
 First, the reproducibility of the previously reported vanadium 10 
(VVO43-)-reductase activity was verified using an identical 
method 18. The indicated components were mixed and incubated 
for 60 min, and changes in solution absorbance at 340 nm due to 
NADPH oxidation were recorded for 60 min (Fig. 2A). When 2 
or 4 µM Vanabin2 was added, NADPH oxidation was 15 
significantly enhanced in a dose-dependent manner. Thus, the 
VV-reductase activity of Vanabin2 was confirmed (Fig. 2A). 
 When molybdate (MoVIO42-) ions were included as the final 
electron acceptor, there was no significant NADPH oxidation 
with or without Vanabin2 (Fig. 2B). The same results were 20 
obtained when tungstate (WVIO42-) ions were used (Fig. 2C). 
These results suggest that Vanabin2 does not act as a Mo- or W-
reductase. 
3.2. Reduction of divalent transition metal cations by 
Vanabin2 coupled with NADPH oxidation 25 
The ability of Vanabin2 to reduce divalent transition metal ions 
was also evaluated. When manganese (MnII) ions were included 
as the final electron acceptor, there was no significant NADPH 
oxidation with or without Vanabin2 (Fig. 3A). 
 With nickel (NiII) ions and Vanabin2, the solution absorbance 30 
at 340 nm gradually increased and then began to decrease after 
approximately 15 min (Fig. 3B). The same trend was observed in 
the absence of Vanabin2, but the absolute values of absorbance 
were always slightly higher than those obtained with Vanabin2. 
 Since cobalt (CoII) ions form a conjugate complex with Tris 35 
and GSH with significant absorbance at 340 nm, a citrate/sodium 
citrate buffer at pH 4.7 was used to examine the reduction of CoII. 
At pH 4.7, Vanabin2 can still form the required SS/SH 
intermediate 20. Auto-oxidation of NADPH was observed in this 
buffer, resulting in a gradual increase in the absorbance at 340 nm 40 
(Fig. 4). When GSH and CoII were mixed and incubated in the 
citrate/sodium citrate buffer, no significant change in absorption 
was observed. When CoII ions were included as the final electron 
acceptor, the absorbance at 340 nm increased gradually at a rate 
not significantly different from that observed with NADPH auto-45 
oxidation. 
 Thus, no evidence of reduction of these three divalent metal 
cations by Vanabin2 was observed. 
3.3. Reduction of copper (CuII) ions by Vanabin2 
 
 
Fig 3. NADPH-coupled assays for the (A) reduction of Mn2+ 
and (B) reduction of NiII. Solid line with solid rectangles 
corresponds to the reaction with 4 µM Vanabin2. Dashed line 
with open rectangles corresponds to the reaction with 2 µM 
Vanabin2. Dotted line with open triangles shows data acquired 
without Vanabin2. The horizontal axis indicates the time after 
initiation of the reaction. The vertical axis indicates the 
decrease in absorbance at 340 nm due to NADPH oxidation.  
 
 
Fig.4. NADPH-coupled assays of the reduction of CoII. The 
dashed line with open rectangles shows data acquired with 
200 μM NADPH, 0.25 U/mL glutathione reductase (GR), 2 
mM GSH, 1 mM CoII ion, and 2 μM Vanabin2. The solid line 
with solid rectangles shows data acquired without Vanabin2. 
The dashed-dotted line corresponds with open triangles to 200 
μM NADPH only. The dotted line with open circles shows 
data acquired with 2 mM GSH and 1 mM CoII only. Note that 
the dotted line with open circles is overlaid on the horizontal 
axis and is difficult to discern. The horizontal axis indicates 
the time after initiation of the reaction. The vertical axis 
indicates the decrease in absorbance at 340 nm due to NADPH 
oxidation. 
 
Copper (CuII) ion is readily reduced by glutathione (GSH) to CuI 
21 and forms a CuI-GS- complex 22. This reaction is extremely 
rapid, taking less than 200 ms23. Therefore, in the coupled assay 
system used here, it was impossible to observe the reduction of 
CuII to CuI by Vanabin2. However, a decrease in solution 5 
absorbance at 340 nm was observed when CuII and GSH were 
combined and incubated over a period of 1-6 h (data not shown). 
This indicates the reverse reaction due to the re-oxidation of CuI 
to CuII by dissolved oxygen in the assay buffer. This re-oxidation 
was exploited in an assay system to examine the Cu-reductase 10 
activity of Vanabin2. 
 In the Cu-reductase assay, bathocuproine (BCS) was used to 
measure the concentration of CuI directly. BCS is known to form 
a complex with CuI, but not with CuII. The complex with CuI 
exhibits an absorbance peak at 480 nm 21. GSH and CuII (2 mM 15 
each) were mixed together with NADPH and GR and the CuI 
concentration was measured every 15 min. The initial solution 
absorbance at 480 nm was about 0.6 (Fig. 5, 0 h). Every hour up 
to 4 h, aliquots were removed from the reaction mixture, mixed 
with BCS assay reagents, and the absorbance at 480 nm was 20 
recorded (Fig. 5, 1–4 h). The absorbance decreased around 2–3 h 
but no differences associated with the presence or absence of 
Vanabin2 could be discerned at any time point. Thus, no evidence 
of the Cu-reductase activity of Vanabin2 was obtained. 
3.4. Reduction potentials 25 
 When standard apparent reduction potentials of each transition 
metal ions were considered, VV could not be reduced to VIV (E0 = 
-0.341 V) by thiol compounds whose reduction potentials (E0 ~ -
0.26 V) were higher than that of VV/VIV 24. The values for 
MnII/Mn0 (E0 = -1.18 V), NiII/Ni0 (E0 = -0.257 V) and CoII/Co0 30 
(E0 = -0.277 V) are similar or lower than those of thiols. 
Reduction of MoVI/MoIV or WVI/WIV could occur by thiols, but 
the behavior of molybdate and tungstate are complicated 
depending on pH. When Vanabin2 was included as the cascade 
shown in Fig. 1 at slightly basic physiological pH of 7.4, only 35 
reduction of VV to VIV was significantly enhanced in a dose-
dependent manner, suggesting that a specific interaction of 
Vanabin2 and VV/VIV occurred, although its nature is unclear. In 
case of copper, reduction potential of CuII/CuI is higher that that 
of thiols, and thus copper (CuII) ion is readily reduced by GSH. 40 
As far as examined in this study, we could not observe any 
specific interaction of Vanabin2 and CuII/CuI as assessed by the 
prevention of reoxidation of CuI.  
3.5. Enzyme kinetics 
 The Vapp and Kapp values for Vanabin2 catalyzed VV reduction 45 
are 1.15 mol-NADPH/min/mol-Vanabin2 and 0.51 mM, 
respectively 18. Vapp for other metal ions examined in this work 
were about 12 to 18 times lower than that for VV. One electron 
reduction of VV has been reported for several flavoenzymes 25, 26. 
Since kinetic parameters were not reported, it is difficult to 50 
compare the enzyme activity among Vanabin2 and these 
flavoenzymes. Further analysis may need to clarify the 
physiological significance of the kinetics of reduction for VV.  
4. Conclusions 
The vanadium-binding protein, Vanabin2, isolated from the 55 
vanadium-rich ascidian Ascidia sydneiensis samea, was evaluated 
for reductase activity using two hexavalent transition metal 
anions, MoVIO42- and WVIO42-, and four divalent cations, MnII, 
NiII, CoII, and CuII. In NADPH-coupled assays, no evidence of 
the reduction of these six metal ions by Vanabin2 was obtained. 60 
Thus far Vanabin2 has shown only VV-reductase activity. This 
specificity may account for the specificity of vanadium 
accumulation in ascidians. 
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